- Home
- Publications
- Publication Search
- Publication Details
Title
Normal and malignant megakaryopoiesis
Authors
Keywords
-
Journal
EXPERT REVIEWS IN MOLECULAR MEDICINE
Volume 13, Issue -, Pages -
Publisher
Cambridge University Press (CUP)
Online
2011-10-21
DOI
10.1017/s1462399411002043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis
- (2011) P. Guglielmelli et al. BLOOD
- SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis
- (2011) H. Chagraoui et al. BLOOD
- Transcription factor networks in erythroid cell and megakaryocyte development
- (2011) L. C. Dore et al. BLOOD
- TAp73α binds the kinetochore proteins Bub1 and Bub3 resulting in polyploidy
- (2011) Patrizia Vernole et al. CELL CYCLE
- Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies
- (2011) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- Clonal hierarchy and allelic mutation segregation in a myelofibrosis patient with two distinct LNK mutations
- (2011) T L Lasho et al. LEUKEMIA
- Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process
- (2010) L. Lordier et al. BLOOD
- Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
- (2010) S. T. Oh et al. BLOOD
- Serum response factor is an essential transcription factor in megakaryocytic maturation
- (2010) S. Halene et al. BLOOD
- Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
- (2010) C. Marty et al. BLOOD
- FOG1 requires NuRD to promote hematopoiesis and maintain lineage fidelity within the megakaryocytic-erythroid compartment
- (2010) G. D. Gregory et al. BLOOD
- Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease
- (2010) H. Akada et al. BLOOD
- JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia
- (2010) J. Li et al. BLOOD
- Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 Signaling
- (2010) Edwin Chen et al. CANCER CELL
- Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells
- (2010) Ann Mullally et al. CANCER CELL
- Therapeutic Potential of Janus-activated Kinase-2 Inhibitors for the Management of Myelofibrosis
- (2010) S. Verstovsek CLINICAL CANCER RESEARCH
- Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis
- (2010) J.-H. Klusmann et al. GENES & DEVELOPMENT
- New Roles for Cyclin E in Megakaryocytic Polyploidization
- (2010) Alexia Eliades et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans
- (2010) Sachie Marubayashi et al. JOURNAL OF CLINICAL INVESTIGATION
- Lnk constrains myeloproliferative diseases in mice
- (2010) Alexey Bersenev et al. JOURNAL OF CLINICAL INVESTIGATION
- Critical Role of Pcid2 in B Cell Survival through the Regulation of MAD2 Expression
- (2010) T. Nakaya et al. JOURNAL OF IMMUNOLOGY
- JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations
- (2010) A Pardanani et al. LEUKEMIA
- The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development
- (2010) C Ragu et al. LEUKEMIA
- IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
- (2010) A Tefferi et al. LEUKEMIA
- LNK mutation studies in blast-phase myeloproliferative neoplasms and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations
- (2010) A Pardanani et al. LEUKEMIA
- Deletions of the transcription factor Ikaros in myeloproliferative neoplasms
- (2010) R Jäger et al. LEUKEMIA
- LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease
- (2010) Dean S. Griffiths et al. NATURE CELL BIOLOGY
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- Somatic Mutations ofIDH1andIDH2in the Leukemic Transformation of Myeloproliferative Neoplasms
- (2010) Anthony Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- LNKMutations inJAK2Mutation–Negative Erythrocytosis
- (2010) Terra L. Lasho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
- (2009) S. Malinge et al. BLOOD
- ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells
- (2009) M. J. Stankiewicz et al. BLOOD
- Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis
- (2009) C. Gekas et al. BLOOD
- Survivin is not required for the endomitotic cell cycle of megakaryocytes
- (2009) Q. Wen et al. BLOOD
- Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells
- (2009) Y. Wang et al. BLOOD
- Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
- (2009) F. H. Grand et al. BLOOD
- ERG Is a Megakaryocytic Oncogene
- (2009) S. Salek-Ardakani et al. CANCER RESEARCH
- NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development
- (2009) Annarita Miccio et al. EMBO JOURNAL
- JAK3: A two-faced player in hematological disorders
- (2009) Melanie G. Cornejo et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mutations of ASXL1 gene in myeloproliferative neoplasms
- (2009) N Carbuccia et al. LEUKEMIA
- JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
- (2009) Mark A. Dawson et al. NATURE
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
- (2009) I. Radtke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1
- (2008) L. Gilles et al. BLOOD
- Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia
- (2008) A. M. Vannucchi et al. BLOOD
- MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
- (2008) P. A. Beer et al. BLOOD
- Primitive erythropoiesis and megakaryopoiesis in the yolk sac are independent of c-myb
- (2008) J. Tober et al. BLOOD
- Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling
- (2008) L. Lordier et al. BLOOD
- SCL and associated proteins distinguish active from repressive GATA transcription factor complexes
- (2008) T. Tripic et al. BLOOD
- Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome
- (2008) Tomohiko Sato et al. BRITISH JOURNAL OF HAEMATOLOGY
- New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition
- (2008) R Chaligné et al. LEUKEMIA
- OTT-MAL Is a Deregulated Activator of Serum Response Factor-Dependent Gene Expression
- (2008) A. Descot et al. MOLECULAR AND CELLULAR BIOLOGY
- Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
- (2007) R. Tiedt et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now